IGF1R and cancer: Upon ectopic expression, PTB-U-box enhances IGF-1R/IR ubiquitination and degradation, thereby inhibiting several key cancer hallmarks, i.e., proliferation, invasion, drug insensitivity and glucose metabolism, and thus retarding the tumor growth in xenograft.